Clarissa Trzesniak

Clarissa Trzesniak

Auto-generated profile, based on publicly available information

Clarissa Trzesniak

Faculdade de Medicina de Itajuba

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2010 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
MFMaria Cecilia Freitas-Ferrari
Maria Cecilia Freitas-Ferrari
JHJaime E.C. Hallak
Jaime E.C. Hallak
CTClarissa Trzesniak
Clarissa Trzesniak
AFAlaor Santos Filho
Alaor Santos Filho
JMJoão Paulo Machado-De-Sousa
João Paulo Machado-De-Sousa
JCJosé Alexandre S. Crippa
José Alexandre S. Crippa

21 July 2010 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
CMCarolina Meneses‐Gaya
Carolina Meneses‐Gaya
AZAntonio W. Zuardi
Antonio W. Zuardi
SLSonia R. Loureiro
Sonia R. Loureiro
JHJaime E. C. Hallak
Jaime E. C. Hallak
CTClarissa Trzesniak
Clarissa Trzesniak
JCJOSE A DE S de Souza CRIPPA
JOSE A DE S de Souza CRIPPA

1 May 2011 in Brain Research
Verified
Journal Article
Closed access
WLWei Liao
Wei Liao
QXQiang Xu
Qiang Xu
Dante MantiniDante Mantini
Dante Mantini
JDJurong Ding
Jurong Ding
JMJoão Paulo Machado-De-Sousa
João Paulo Machado-De-Sousa
HCHuafu Chen
Huafu Chen

1 March 2010 in Brazilian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
JHJaime E. C. Hallak
Jaime E. C. Hallak
JMJoão Paulo Machado-De-Sousa
João Paulo Machado-De-Sousa
JCJosé Alexandre S. Crippa
José Alexandre S. Crippa
RSRafael Faria Sanches
Rafael Faria Sanches
CTClarissa Trzesniak
Clarissa Trzesniak
AZAntonio Waldo Zuardi
Antonio Waldo Zuardi
OBJECTIVE: The last decade has seen increasing evidence of dysfunctions in the endogenous cannabinoid system in schizophrenia and of its relationship with the typical cognitive impairment of the disorder. Studies in animal models, healthy volunteers, and psychotic patients clearly suggest an antipsychotic-like effect of cannabidiol. This study investigated the effects of cannabidiol on selective attention in 28 schizophrenic patients using the Stroop Color Word Test and on these patients' electrodermal responsiveness to auditive stimuli. METHOD: The subjects attended two experimental sessions, the first one without the administration of drugs. In the second session the subjects were divided into three groups that received either a single dose of cannabidiol 300mg or cannabidiol 600mg or placebo. RESULTS: The three groups did not differ significantly with respect to electrodermal measures in the two experimental sessions. When the first and second sessions were compared improved performance was found in all three groups, with patients who received placebo and cannabidiol 300mg performing better than those who received cannabidiol 600mg. CONCLUSION: The single, acute administration of cannabidiol seems to have no beneficial effects on the performance of schizophrenic patients in the Stroop Color Word Test, although the hypothesis that chronic administration may lead to improvement cannot be disregarded.

1 January 2011 in Schizophrenia Research
Verified
Journal Article
Closed access
CTClarissa Trzesniak
Clarissa Trzesniak
IOIrismar R. Oliveira
Irismar R. Oliveira
MKMatthew J. Kempton
Matthew J. Kempton
AAAmanda Galvão-De Almeida
Amanda Galvão-De Almeida
MCMarcos H.N. Chagas
Marcos H.N. Chagas
JCJosé Alexandre S. Crippa
José Alexandre S. Crippa

1 June 2010 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
KAKátia C. Arrais
Kátia C. Arrais
JMJoão Paulo Machado-De-Sousa
João Paulo Machado-De-Sousa
CTClarissa Trzesniak
Clarissa Trzesniak
AFAlaor Santos Filho
Alaor Santos Filho
MFMaria Cecília F. Ferrari
Maria Cecília F. Ferrari
JCJosé Alexandre S. Crippa
José Alexandre S. Crippa